A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NCT05152563 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Eosinophilic Gastritis
Eosinophilic Duodenitis

Interventions

DRUG: AK002
OTHER: Placebo

Sponsor

Allakos Inc.